Elevai Labs
ELAB
4 hedge funds and large institutions have $57.7K invested in Elevai Labs in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
70% less capital invested
Capital invested by funds: $191K → $57.7K (-$133K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$45.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$86.5K |
ELAB Hedge Fund Activity: Q2 2025 in Review
4 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Elevai Labs (ELAB) for Q2 2025, worth a combined $57.7K — down 70% from $191K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ELAB positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $45.4K. The largest seller was Sabby Management, cutting an estimated $86.5K.
- 4 institutional investors held Elevai Labs (ELAB) as of Q2 2025, up from 3 in Q1 2025.
- Funds reported $57.7K of Elevai Labs stock for Q2 2025, down 70% quarter-over-quarter.
- 1 fund opened new Elevai Labs positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest Elevai Labs buyer in Q2 2025 was Citadel Advisors, an estimated $45.4K added.
- The largest Elevai Labs seller in Q2 2025 was Sabby Management, an estimated $86.5K sold.
Based on aggregated 13F filings for Q2 2025.